Fig. 6

Association between clinicopathological features, immunohistochemical factors and distant metastasis-free survival over the first 5 years in the Her2-enriched group of breast cancer patients
Association between clinicopathological features, immunohistochemical factors and distant metastasis-free survival over the first 5 years in the Her2-enriched group of breast cancer patients